Erratum to: Impact of cardiovascular magnetic resonance on management and clinical decision-making in heart failure patients (Journal of Cardiovascular Magnetic Resonance (2013) 15(1), (S1097664723008050), (10.1186/1532-429X-15-89));Impact of cardiovascular magnetic resonance on management and clinical decision-making in heart failure patients

Journal of Cardiovascular Magnetic Resonance

Volumn 15, Issue 1, 2013, Pages

  Abbasi, Siddique A ^a,b   Ertel, Andrew ^b   Shah, Ravi V ^a,c   Dandekar, Vineet ^b   Chung, Jaehoon ^b   Bhat, Geetha ^b,d   Desai, Ankit A ^b   Kwong, Raymond Y ^a   Farzaneh Far, Afshin ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d ADVOCATE CHRIST MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ADULT; ANGIOGRAPHY; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL DECISION MAKING; DEVICE THERAPY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MUSCULAR DYSTROPHY; MYOCARDITIS; NONISCHEMIC CARDIOMYOPATHY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVASCULARIZATION;

ADULT; AGED; DECISION SUPPORT TECHNIQUES; FEMALE; HEART FAILURE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ODDS RATIO; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84885014000     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-16-20     Document Type: Erratum

References (23)

1. Identifying the etiology: a systematic approach using delayed-enhancement cardiovascular magnetic resonance. Senthilkumar A, Majmudar MD, Shenoy C, Kim HW, Kim RJ, Heart failure clinics 2009 5 3 349 67 vi 10.1016/j.hfc.2009.02.009 19564013
2. The role of cardiovascular magnetic resonance imaging in heart failure. Karamitsos TD, Francis JM, Myerson S, Selvanayagam JB, Neubauer S, J Am Coll Cardiol 2009 54 15 1407 24 10.1016/j.jacc.2009.04.094 19796734
3. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, Bijsterveld P, Ridgway JP, Radjenovic A, Dickinson CJ, et al. Lancet 2012 379 9814 453 60 10.1016/S0140-6736(11)61335-4 22196944
4. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. Klem I, Heitner JF, Shah DJ, Sketch MH Jr, Behar V, Weinsaft J, Cawley P, Parker M, Elliott M, Judd RM, et al. J Am Coll Cardiol 2006 47 8 1630 8 10.1016/j.jacc.2005.10.074 16631001
5. Cardiovascular magnetic resonance in pericardial diseases. Bogaert J, Francone M, J Cardiovasc Magn Reson 2009 11 14 10.1186/1532-429X-11-14 19413898
6. Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction. Weinsaft JW, Kim HW, Shah DJ, Klem I, Crowley AL, Brosnan R, James OG, Patel MR, Heitner J, Parker M, et al. J Am Coll Cardiol 2008 52 2 148 57 10.1016/j.jacc.2008.03.041 18598895 (Pubitemid 351885445)
7. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Al-Saadi N, Nagel E, Gross M, Bornstedt A, Schnackenburg B, Klein C, Klimek W, Oswald H, Fleck E, Circulation 2000 101 12 1379 83 10.1161/01.CIR.101.12.1379 10736280 (Pubitemid 30169858)
8. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. Tandri H, Saranathan M, Rodriguez ER, Martinez C, Bomma C, Nasir K, Rosen B, Lima JA, Calkins H, Bluemke DA, J Am Coll Cardiol 2005 45 1 98 103 10.1016/j.jacc.2004.09.053 15629382 (Pubitemid 40052034)
9. Cardiac magnetic resonance in hypertrophic cardiomyopathy. To AC, Dhillon A, Desai MY, JACC Cardiovasc Imaging 2011 4 10 1123 37 10.1016/j.jcmg.2011.06. 022 21999873
10. T2 quantification for improved detection of myocardial edema. Giri S, Chung YC, Merchant A, Mihai G, Rajagopalan S, Raman SV, Simonetti OP, J Cardiovasc Magn Reson 2009 11 56 10.1186/1532-429X-11-56 20042111
11. Using a magnet to strike gold. Baliga RR, Young JB, Heart Fail Clin 2009 5 3 x-x 19564007
12. HFSA 2010 comprehensive heart failure practice guideline. Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, Givertz MM, Katz SD, Klapholz M, Moser DK, Heart Failure Society of A, et al. J Card Fail 2010 16 6 1 194 10.1016/j.cardfail.2010.04.004 20610207
13. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E, Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized P, J Cardiovasc Magn Reson 2008 10 35 10.1186/1532-429X-10-35 18605997
14. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ, Lancet 2001 357 9249 21 8 10.1016/S0140-6736(00)03567-4 11197356 (Pubitemid 32056497)
15. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, Pennell DJ, Circulation 2003 108 1 54 9 10.1161/01.CIR.0000078641.19365.4C 12821550 (Pubitemid 36859020)
16. The «wavefront phenomenon» of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Reimer KA, Jennings RB, Lab Invest 1979 40 6 633 44 449273 (Pubitemid 9191795)
17. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, Vogelsberg H, Fritz P, Dippon J, Bock CT, et al. Circulation 2006 114 15 1581 90 10.1161/CIRCULATIONAHA.105.606509 17015795 (Pubitemid 44547428)
18. Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations. Verhaert D, Richards K, Rafael-Fortney JA, Raman SV, Circ Cardiovasc Imaging 2011 4 1 67 76 10.1161/CIRCIMAGING.110.960740 21245364
19. Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology. Assomull RG, Shakespeare C, Kalra PR, Lloyd G, Gulati A, Strange J, Bradlow WM, Lyne J, Keegan J, Poole-Wilson P, et al. Circulation 2011 124 12 1351 60 10.1161/CIRCULATIONAHA.110.011346 21900085
20. EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase. Bruder O, Schneider S, Nothnagel D, Dill T, Hombach V, Schulz-Menger J, Nagel E, Lombardi M, van Rossum AC, Wagner A, et al. J Am Coll Cardiol 2009 54 15 1457 66 10.1016/j.jacc.2009.07.003 19682818
21. Heart disease and stroke statistics-2012 update: a report from the American heart association. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, et al. Circulation 2012 125 1 2 220 22179539
22. The Heart Failure Revascularisation Trial (HEART). Cleland JG, Calvert M, Freemantle N, Arrow Y, Ball SG, Bonser RS, Chattopadhyay S, Norell MS, Pennell DJ, Senior R, Eur J Heart Fail 2011 13 2 227 33 10.1093/eurjhf/hfq230 21156659
23. Coronary-artery bypass surgery in patients with left ventricular dysfunction. Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, Ali IS, Pohost G, Gradinac S, Abraham WT, et al. N Engl J Med 2011 364 17 1607 16 10.1056/NEJMoa1100356 21463150